Kyntra Bio Inc(KYNB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KYNB Kyntra Bio Inc

盘前交易 09-24 09:29:11 EDT

7.25

-0.03

-0.41%

最高7.30	最低7.03	成交量2.91万
今开7.09	昨收7.28	日振幅3.71%
总市值2,933万	流通市值2,582万	总股本404.54万
成交额20.98万	换手率0.82%	流通股本356.12万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KYNB","market":"US","secType":"STK","nameCN":"Kyntra Bio Inc","latestPrice":7.25,"timestamp":1790193600000,"preClose":7.28,"halted":0,"volume":29102,"delay":0,"changeRate":-0.004120879120879155,"floatShares":3561200,"shares":4045445,"eps":45.266125,"marketStatus":"盘前交易","change":-0.03,"latestTime":"09-24 09:29:11 EDT","open":7.09,"high":7.3,"low":7.03,"amount":209822,"amplitude":0.037088,"askPrice":7.6,"askSize":100,"bidPrice":6.83,"bidSize":54,"shortable":3,"etf":0,"ttmEps":45.266125,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790256600000},"marketStatusCode":1,"adr":0,"listingDate":1415941200000,"exchange":"NASDAQ","adjPreClose":7.25,"postHourTrading":{"tag":"盘后","latestPrice":7.25,"preClose":7.25,"latestTime":"16:10 EDT","volume":7,"amount":50.75,"timestamp":1790194204865,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8207734464006375},"requestUrl":"/m/hq/s/KYNB/wiki","defaultTab":"wiki","newsList":[{"id":"1192420942","title":"Kyntra Bio发布罗沙司他新数据：无论环状铁粒幼细胞状态如何，均能改善低危MDS贫血患者输血独立性","url":"https://stock-news.laohu8.com/highlight/detail?id=1192420942","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192420942?lang=zh_cn&edition=full","pubTime":"2026-06-12 04:06","pubTimestamp":1781208416,"startTime":"0","endTime":"0","summary":"Kyntra Bio Inc公布了其药物罗沙司他的最新研究数据。数据显示，对于因低危骨髓增生异常综合征导致贫血的患者，无论其环状铁粒幼细胞状态如何，罗沙司他治疗均能显著改善患者的输血独立性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYNB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kyntrabio.com","stockEarnings":[{"period":"1week","weight":-0.0473},{"period":"1month","weight":-0.0915},{"period":"3month","weight":0.0447},{"period":"6month","weight":0.1002},{"period":"1year","weight":-0.3943},{"period":"ytd","weight":-0.1743}],"compareEarnings":[{"period":"1week","weight":0.0182},{"period":"1month","weight":0.0057},{"period":"3month","weight":0.0456},{"period":"6month","weight":0.2109},{"period":"1year","weight":0.1577},{"period":"ytd","weight":0.126}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kyntra Bio, Inc.于1993年在美国特拉华州注册成立。该公司是一家生物制药公司，专注于癌症生物学和贫血前沿领域的新疗法开发。该公司正在开发FG-3246，这是一种潜在的靶向CD46的first-in-class抗体药物偶联物，用于治疗转移性去势抵抗性前列腺癌和潜在的其他癌症。该计划还包括FG-3180的开发，这是一种相关的CD46靶向正电子发射断层扫描生物标志物和显像剂。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.171748},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.039992},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.057428},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.116567},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.040314},{"month":6,"riseRate":0.666667,"avgChangeRate":0.006331},{"month":7,"riseRate":0.5,"avgChangeRate":-0.040858},{"month":8,"riseRate":0.416667,"avgChangeRate":0.023653},{"month":9,"riseRate":0.416667,"avgChangeRate":-0.014273},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.070226},{"month":11,"riseRate":0.727273,"avgChangeRate":0.07854},{"month":12,"riseRate":0.636364,"avgChangeRate":0.096082}],"exchange":"NASDAQ","name":"Kyntra Bio Inc","nameEN":"Kyntra Bio Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kyntra Bio Inc(KYNB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kyntra Bio Inc(KYNB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kyntra Bio Inc,KYNB,Kyntra Bio Inc股票,Kyntra Bio Inc股票老虎,Kyntra Bio Inc股票老虎国际,Kyntra Bio Inc行情,Kyntra Bio Inc股票行情,Kyntra Bio Inc股价,Kyntra Bio Inc股市,Kyntra Bio Inc股票价格,Kyntra Bio Inc股票交易,Kyntra Bio Inc股票购买,Kyntra Bio Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kyntra Bio Inc(KYNB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kyntra Bio Inc(KYNB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}